Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-27 @ 4:40 AM
Study NCT ID:
NCT04044950
Status:
WITHDRAWN
Last Update Posted:
2020-09-22
First Post:
2019-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-17
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-01
First Submit QC Date:
None
Study First Post Date:
2019-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-21
Last Update Post Date:
2020-09-22
Last Update Post Date Type:
ACTUAL